Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase.

Hypertension
Isabella BaruscottiRaghvendra K Dubey

Abstract

Endothelial progenitor cells (EPCs) repair damaged endothelium and promote capillary formation, processes involving receptor tyrosine kinases (RTKs) and heme oxygenase 1 (HO-1). Because estradiol augments vascular repair, we hypothesize that estradiol increases EPC proliferation and capillary formation via RTK activation and induction of HO-1. Physiological concentrations of estradiol (10 nmol/L) increased EPC-induced capillary sprout and lumen formation in matrigel/fibrin/collagen systems. Propyl-pyrazole-triol (PPT; 100 nmol/L; estrogen receptor [ER]-alpha agonist), but not diarylpropionitrile (ER-beta agonist), mimicked the stimulatory effects of estradiol on capillary formation, and methyl-piperidino-pyrazole (ER-alpha antagonist) abolished the effects of estradiol and PPT. Three different RTK activators (vascular endothelial growth factor, hepatocyte growth factor, and stromal derived growth factor 1) mimicked the capillary-stimulating effects of estradiol and PPT. SU5416 (RTK inhibitor) blocked the stimulatory effects of estradiol and PPT on capillary formation. Estradiol increased HO-1 expression by 2- to 3-fold, an effect blocked by SU5416, and PPT mimicked the effects of estradiol on HO-1. The ability of estradiol to e...Continue Reading

References

Jun 11, 1999·The New England Journal of Medicine·M E Mendelsohn, R H Karas
Aug 3, 2000·American Journal of Physiology. Heart and Circulatory Physiology·P KoehneC Bührer
Jan 9, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·D W Losordo, J M Isner
Feb 22, 2001·American Journal of Physiology. Renal Physiology·R K Dubey, E K Jackson
Feb 24, 2001·Journal of Human Genetics·S OgawaS Inoue
Dec 4, 2001·Annals of Internal Medicine·H N HodisUNKNOWN Estrogen in the Prevention of Atherosclerosis Trial Research Group
Jun 1, 2002·Circulation Research·Gary PareMichael E Mendelsohn
May 14, 2005·Antioxidants & Redox Signaling·Giovanni Li VoltiNader G Abraham
Mar 7, 2007·The Journal of Experimental Medicine·Jessy DeshaneAnupam Agarwal
Jun 27, 2008·Pharmacological Reviews·Virginia M Miller, Sue P Duckles
Sep 5, 2008·Current Opinion in Lipidology·Jozef DulakAlicja Jozkowicz
Jun 25, 2009·Molecular and Cellular Endocrinology·Matthias R MeyerMatthias Barton

❮ Previous
Next ❯

Citations

Jul 26, 2012·Angiogenesis·Nicolas ClereSébastien Faure
Jan 20, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kei IzumiyamaKen Okumura
Dec 24, 2010·Current Opinion in Nephrology and Hypertension·Xiao-Ping Yang, Jane F Reckelhoff
Feb 10, 2012·American Journal of Physiology. Endocrinology and Metabolism·Victor H Urbieta-CaceresLilach O Lerman
Sep 24, 2013·Antioxidants & Redox Signaling·Magdalena KozakowskaAlicja Jozkowicz
Dec 5, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Hiroshi IijimaSusumu Kitanaka
Oct 5, 2017·Journal of the American Heart Association·Matthew L TopelArshed A Quyyumi
Dec 4, 2019·Hypertension·Raghvendra K DubeyEdwin K Jackson
Sep 29, 2020·Frontiers in Physiology·Enkhjargal BudbazarFrancesca Seta
Jun 19, 2016·The American Journal of Pathology·Jeannette Rudzitis-AuthMatthias W Laschke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.